OmniAb (OABI) Common Equity (2021 - 2026)
OmniAb's (OABI) quarterly Common Equity came in at $262.6 million in Q1 2026, down 3.97% year-on-year from $273.5 million in Q1 2025, and down 1.64% on a QoQ basis from $267.0 million in Q4 2025.
OmniAb (OABI) Common Equity (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Common Equity data on file, last reported at $262.6 million in Q1 2026.
- On a quarterly basis, Common Equity fell 3.97% year-over-year to $262.6 million in Q1 2026; TTM through Mar 2026 was $262.6 million, a 3.97% decrease from a year earlier, with the FY2025 full-year figure at $267.0 million, down 7.16% from the prior year.
- Common Equity for Q1 2026 stood at $262.6 million, down from $267.0 million in the prior quarter.
- Over the last five years, Common Equity for OABI reached as high as $341.4 million in Q4 2022 and fell as low as $224.9 million in Q1 2022.
- Historically, Common Equity has averaged $285.7 million across 5 years, with a median of $287.6 million in 2024.
- Across the five-year window, Common Equity jumped 1509933.93% in 2022 and decreased 11.87% in 2024, its largest moves.
- Year by year, Common Equity stood at $341.4 million in 2022, then fell by 7.85% to $314.6 million in 2023, then slipped by 8.57% to $287.6 million in 2024, then fell by 7.16% to $267.0 million in 2025, then dropped by 1.64% to $262.6 million in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $262.6 million in Q1 2026, $267.0 million in Q4 2025, and $277.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn | 262.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 262.65 Mn |
| Dec 31, 2025 | 267.03 Mn |
| Sep 30, 2025 | 277.44 Mn |
| Jun 30, 2025 | 262.06 Mn |
| Mar 31, 2025 | 273.52 Mn |
| Dec 31, 2024 | 287.62 Mn |
| Sep 30, 2024 | 291.73 Mn |
| Jun 30, 2024 | 294.18 Mn |
| Mar 31, 2024 | 301.39 Mn |
| Dec 31, 2023 | 314.59 Mn |
| Sep 30, 2023 | 324.55 Mn |
| Jun 30, 2023 | 333.81 Mn |
| Mar 31, 2023 | 340.80 Mn |
| Dec 31, 2022 | 341.37 Mn |
| Sep 30, 2022 | 232.71 Mn |
| Jun 30, 2022 | 226.94 Mn |
| Mar 31, 2022 | 224.92 Mn |
| Dec 31, 2021 | 234.31 Mn |
| Sep 30, 2021 | -6.90 Mn |
| Jun 30, 2021 | 15,029.00 |